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ABSTRACT  
Description of the Problem: Pharmacists can play a crucial role in monitoring, counseling, and providing adherence checks across 
practice pharmacy settings; but they may not gain experience in this area until after graduating from pharmacy school.  
Statement of Innovation:  Students participated in an intentionally aligned team-based learning session followed by completion of an 
HIV patient treatment worksheet and an HIV patient care simulation. This sequence was assessed using the HIV Treatment Knowledge 
Scale. 
Description of the Innovation: Second-year pharmacy students (N=48, 98% response rate) participated in a baseline knowledge 
assessment before a four-hour HIV team-based learning (TBL) session, which included the use of an online HIV Patient Management 
Simulator. Students were administered the scale again post-session. Three days before the simulation, students had access to an HIV 
patient treatment worksheet that was required to be completed before the simulation. Ten days after the initial assessment, students 
participated in an HIV patient simulation where they proposed a new antiretroviral plan while also addressing monitoring, barriers, 
and maximizing adherence for the patient. Post-simulation, students were again administered the scale. Data were analyzed using 
descriptive statistics, Wilcoxon and paired t-tests, as appropriate. 
Critical Analysis: A total of 48 second-year pharmacy students participated.  HIV knowledge increased significantly post-TBL (p < 0.001). 
Post-simulation, scores improved, but not significantly (p = 0.291). Knowledge on 15 of the 21 items on the HIV Treatment Knowledge 
Scale significantly improved from pre-TBL to post-simulation (p ≤ 0.025).  
Next Steps: Future investigation should focus on the impact that HIV simulation training has on skills, abilities, confidence, and 
empathy.  
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Description of the Problem 
Through hands-on learning and application of knowledge to 
unique situations, patient simulations are effective 
supplementations to didactic education.1 Currently, there is a 
paucity of evidence surrounding simulated HIV patient 
encounters for pharmacy students. Additionally, there is a need 
to improve HIV knowledge and comfort among pharmacists.2 
One study demonstrated an increase of HIV knowledge  
forxxx third-yearxxxxmedicalxxxxstudentsxxxxafterxxxxpatient  
simulation workshops.3-4 Therefore, a simulated patient 
encounter with an HIV positive patient was developed  
and implemented in an infectious diseases course.  
 
Statement of the Innovation 
Through hands-on learning and application of knowledge to 
unique situations, patient simulations are useful 
supplementations to didactic learning and aid in knowledge 
retention.  Faculty involved in teaching the HIV content 
developed an intentional sequence of team-based learning,  
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using an online HIV Patient Management Simulator,5 and a 
patient simulation to allow students to apply their clinical 
knowledge and counseling skills. In addition, learning was 
assessed through pre-TBL, post-TBL and post-simulations 
administrations of the HIV Treatment Knowledge Scale. 
 
Description of the Innovation 
Study participants  
The study was found to be exempt by the University’s 
Institutional Review Board. Participants (N=48) were second-
year PharmD students. This study was completed during the 
spring semester 2018 using a pre-/post-test study design in a 
required infectious disease module. (Figure 1) 
 
HIV Treatment Knowledge Scale 
At the beginning of the three-week module, each student was 
given the HIV Treatment Knowledge Scale to complete in class 
via paper to establish a baseline of HIV therapy knowledge. The 
HIV Treatment Knowledge Scale is a 21-item scale) for 
measuring pharmacy student knowledge of HIV treatment 
issues through indicating if the answer is ‘true’ or ‘false’, or if 
they ‘don't know.’6 Some validity evidence is available 
indicating good test-retest reliability (r=0.83) and reliability 
(0.90).6  A total score is calculated  with this tool by adding all 
correct answers and dividing by the total number of scale items, 
with a higher total score indicating greater HIV treatment 
knowledge.6 Scores range from zero to 216  The validation study 
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also showed that scores on the HIV Treatment Knowledge Scale 
correlated with general knowledge of HIV after a two-week 
test-retest, which allowed for assessment of knowledge in this 
study.6 
 
Team-based Learning Session 
TBL is one of the pedagogies used for the course with both 
students and instructors being well-versed in the 
implementation of TBL. Students are assigned at the beginning 
of each academic year to a TBL group that is used for all courses 
over the year. Each TBL group has between 5 to 6 students that 
were randomly assigned based on the following criteria:  
student StrengthsFinders results, gender and race/ethnicity. To 
keep teams balanced at least 2 students of race/ethnicity 
diversity where on each team as well as least 2 male students 
per team when possible.  
 
Students engaged in a four-hour TBL session covering HIV. The 
pre-work consisted of approximately five hours of assigned 
reading covering HIV guidelines, including HIV background, 
pathophysiology, treatment, and monitoring parameters, as 
well as viewing online videos from YouTube related to how HIV 
works and medication mechanisms of action. During the 
session, students completed a 10-question individual readiness 
assessment test (iRAT) covering the pre-class material followed 
by an identical team readiness assessment test (tRAT). Students 
were given a total of 45 minutes to complete both the iRAT (20 
minutes) and tRAT (25 minutes). During this time, students 
were not allowed to use any notes or other materials. After all 
teams had completed the tRAT, the questions and answers 
were reviewed by each team revealing their answer choices (i.e. 
simultaneous reporting) and classroom discussions on why 
answers were chosen. The instructor provided further 
clarification for any questions not understood. Students then 
listened to a mini-lecture covering HIV diagnosis, assessment, 
treatment, monitoring, and adherence for reinforcement. In 
the last two hours of the class, after the mini-lecture, students 
engaged in a team-based application exercise using an online 
HIV Patient Management Simulator.5 This interactive 
simulation had a total of six scenarios where students were 
asked to choose the most appropriate treatment and 
monitoring options for patients based on adherence factors, 
laboratory values, side effects, comorbidities, and medication 
interactions. The simulated cases included  a patient with a new 
HIV diagnosis regarding initial HIV therapy, a patient requiring 
adjustment of their HIV regimen due to complications from 
therapy, patients with barriers to therapy, and a patient 
requiring management of an opportunistic infection.  Students 
were instructed to complete as many scenarios as possible 
within the time given (1.25 hours). During the last 45 minutes, 
the scenarios and appropriate responses were reviewed with 
student participation in explaining the answers chosen and 
instructor providing clarifications as needed. Afterward, 
students were administered the HIV Treatment Knowledge 
Scale in class via paper. 
Patient Care Simulation 
Ten days after initial assessment and three days post-TBL 
session, students participated in an HIV patient care simulation. 
The week prior to the simulation, students were provided the 
patient case, as well as instructions for the simulation. The 
patient case consisted of a patient diagnosed with HIV two 
years prior that had not received treatment. The patient had 
oropharyngeal and esophageal candidiasis, as well as a 
decreased CD4 count and increased HIV viral load. The students 
were expected to counsel the patient on new therapies for HIV 
and candidiasis. Students were required to complete an HIV 
patient treatment worksheet that they turned in prior to 
interacting with the patient. The patient treatment worksheet 
required students to choose the most appropriate treatments 
for the patient’s candidiasis, as well as their uncontrolled HIV. 
Variables that were assessed from the worksheet included: 
pharmacologic treatment suggestions for ART, explanations of 
surrogate markers and use in monitoring HIV, and explanations 
of any monitoring (clinical & lab) that the patient needs based 
on therapy choice. Following their assessment, students 
defined the drug, dose, schedule, duration of therapy, side 
effects, and other important counseling points for each 
treatment.  
 
During the simulation, students were placed in the role of an 
Advanced Pharmacy Practice Experience (APPE) student in an 
HIV clinic that had been instructed to discuss their plan with the 
patient. During the simulation, students were not permitted to 
take notes or use electronic devices. Students had 15 minutes 
to individually counsel the patient on the following: 
 
1. An appropriate antiretroviral regimen for the given 
patient (drug, dosage, schedule and duration of 
therapy, major side effects). 
2. Any monitoring (clinical & laboratory) that the patient 
would need to have completed. 
3. Surrogate markers and their use in monitoring HIV 
disease. 
4. An appropriate treatment regimen for the patient’s 
oropharyngeal candidiasis opportunistic infection 
(drug, dosage, schedule and duration of therapy). 
5. Potential barriers to medication adherence and 
strategies to overcome these barriers and maximize 
treatment adherence. 
 
The patient simulation was conducted in the pharmacy 
simulation clinic. Each individual patient counseling session was 
video-recorded for use in assessing student performance. 
Course faculty watched the videos to assess each student using 
a rubric that assessed student knowledge based on the five 
objectives of the simulation, plus patient interaction skills (i.e. 
closure and teach back, pace and flow) using a 4-point Likert 
scale (i.e., Unsatisfactory, Needs Development, Satisfactory, 
and Commendable) (available on request)  The patients for the 
counseling simulation were played by faculty, residents or 
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Advanced Pharmacy Practice Experience (APPE) students and 
were given a role-play guide to ensure consistency between 
encounters. The patients also scored the students on their 
patient counseling skills (i.e. word use, professionalism, 
empathy) using a 4-point Likert Scale.    At the end of the 
simulation, students completed the HIV Treatment Knowledge 
Scale a third time via a paper copy.(Figure 1).   
 
Findings 
Data were collected and de-identified prior to analysis, and all 
surveys were double-keyed to ensure accuracy of entry. Data 
were analyzed in SPSS v. 25.0 (IBM Corp., Armonk, NY). An a 
priori ɑ = 0.05 was used for statistical significance. Descriptive 
statistics and a chi-square analysis were utilized to evaluate 
differences in demographic data.  
 
There was a total of 48 second-year professional pharmacy 
students who participated in the study (18 male, 30 female). 
There were no significant differences in HIV treatment 
knowledge based on gender or ethnicity. There was a significant 
difference between total correct responses from pre-TBL to 
post-TBL and pre-TBL to post-simulation (p < 0.001), but not 
significantly from post-TBL to post-simulation (p = 0.291).  
 
Table 1 provides the total response correct based on each item. 
Total correct responses increased significantly from pre-TBL to 
post-TBL on 13 of the 21 survey items (p < 0.05), although no 
significant differences were observed from post-TBL to post-
simulation. Knowledge on 15 of the 21 items on the HIV 
Treatment Knowledge Scale significantly improved from pre-
TBL to post-simulation (p ≤ 0.025). Item numbers 5 and 13 had 
a significant increase in knowledge only from pre-TBL to post-
simulation. Correct responses on 16 of the 21 items on the HIV 
Treatment Knowledge Scale increased from post-TBL to post-
simulation, although not significantly.   
 
Critical Analysis 
The results of this study suggest that the TBL session produced 
an increase in HIV knowledge, which was sustained after 
completing a simulation experience. Although there was no 
statistically significant difference from post-TBL to post-
simulation, there was a trend in knowledge improvement for 16 
of the 21 items on the HIV Treatment Knowledge Scale. These 
findings may be incidental; however, the change may also not 
have been observable to be statistically significant due to a 
small sample size. 
Other studies have demonstrated an increase in student 
knowledge following a simulation.  In a medication adherence 
study by Sutton and colleagues, medical students took part in 
simulated highly active antiretroviral therapy (HAART). 
Students valued the experience and significantly improved their 
insight, attitude, and recognition towards medication 
adherence and its related challenges.7 In a study by Serag-Bolos 
and colleagues, an oncology simulation significantly improved 
pharmacy student therapeutic knowledge.4 One way to use a 
simulation event alongside of a TBL session that would allow for 
a better reinforcement of student knowledge would be to have 
a debriefing session with the students immediately following 
the simulation with a faculty member to allow for 
reinforcement or correction of observed concepts and skills.  
Additionally, the simulation event could be designed in a 
manner that would reinforced correct concepts that would help 
in reinforcement of knowledge learned during the didactic 
session.  
  
The knowledge test that was utilized in this study was neither 
designed nor intended to capture skills-based outcomes.  The 
patient care simulation was an application of the knowledge 
students have acquired during their preparation for and 
participation in the TBL session. This activity addresses the 
Accreditation Council for Pharmacy Education (ACPE) Standards 
3 and 10, as well as the Center for the Advancement of 
Pharmaceutical Education (CAPE) Outcomes 3 and 4.8,9 Both the 
ACPE Standards and CAPE Outcomes recognize the clear and 
significant role of communication on patient care. This 
simulation allows the students to engage in active learning 
while practicing communication skills. While this study was not 
mapped to Entrustable Professional Activity (EPA) domains or 
the Pharmacists’ Patient Care Process (PPCP), the simulation 
could be beneficial in meeting such outcomes and in emulating 
the PPCP, as students worked through collecting information, 
assessing information, planning care, implementing the plan, 
and discussing monitoring and follow-up. 
 
To better assess student development, a scale to assess EPAs 
and/or the PCPP can be utilized in future research, as the 
treatment knowledge scale does not measure student 
development. Another limitation was faculty and students 
played the patient role without stringent guidelines regarding 
patient sexuality and how to respond to questions or with 
questions to student learners. Actors may provide a more 
realistic patient role in simulations, as they would more closely 
portray an actual patient.10  
 
Next Steps  
Similar activities at other institutions may assist in preparing 
students for future practice. However, further research should 
examine the impact on skills and abilities, student confidence, 
and student empathy through this experience.  In the future, 
we plan to use the online National HIV curriculum to better 
prepare students for the TBL session through course modules 
and self-study cases. 
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Figure 1: Timeline of the Intervention 
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Table 1. Differences between correct responses on each HIV Treatment Knowledge Scale Item 
Scale Item 
Total Correct Responses 
N(%) 
p-values 
Pre-
TBL 
Post-
TBL 
Post-
Sim 
Pre-TBL 
vs Post-
TBL 
Post TBL 
vs Post-
Sim 
Pre-TBL 
vs Post-
Sim 
1. Once the HIV viral load results are “undetectable,” HIV 
medications should be stopped (F) 
36 
(75%) 
47 
(98%) 
48 
(100%) 
0.011 1.00 0.010 
2. If HIV medications are not taken at the right time of day, HIV 
drug resistance can occur (T) 
18 
(36%) 
23 
(48%) 
17 
(35%) 
0.152 0.665 0.220 
3. HIV is cured when the HIV viral load blood test result is 
“undetectable” (F) 
33 
(69%) 
46 
(96%) 
48 
(100%) 
0.002 0.317 0.001 
4. Condoms during sex are not needed when the HIV viral load 
blood test results are at “undetectable” levels (F) 
43 
(90%) 
47 
(98%) 
47 
(98%) 
0.046 0.317 0.025 
5. It is better to take a half dose of the HIV medications than 
stopping the HIV combination medications completely (F) 
14 
(29%) 
21 
(44%) 
26 
(54%) 
0.129 0.199 0.004 
6. One can get infected with a drug resistant type of HIV (T) 29 
(60%) 
41 
(85%) 
37 
(77%) 
0.001 0.258 0.025 
7. HIV medications can cause unpleasant side effects (e.g. 
nausea, diarrhea, vomiting) (T) 
45 
(94%) 
47 
(98%) 
45 
(94%) 
0.157 0.83 0.679 
8. If sexual partners are both HIV+ condoms are no longer 
needed (F) 
26 
(54%) 
41 
(85%) 
42 
(88%) 
0.011 1.00 0.008 
9. Treatments are available to reduce HIV medication side 
effects (T) 
36 
(75%) 
38 
(79%) 
44 
(92%) 
0.182 0.189 0.051 
10. Recreational drugs (e.g. ecstasy) can affect the 
effectiveness of HIV medications (T) 
35 
(73%) 
38 
(79%) 
40 
(83%) 
0.330 0.763 0.207 
11. Providing HIV medications to a pregnant woman reduces 
the baby’s risk of being infected with HIV (T) 
22 
(46%) 
46 
(96%) 
47 
(98%) 
< 0.001 0.655 < 0.001 
12. There currently exists an HIV vaccine that prevents HIV 
infection (F) 
37 
(77%) 
42 
(88%) 
40 
(83%) 
0.782 0.157 0.166 
13. HIV medications can be taken at a different time of day on 
weekends or holidays (F) 
33 
(69%) 
33 
(69%) 
37 
(77%) 
0.275 0.079 0.005 
14. Over-the-counter herbal pills (e.g., St. John’s Wort) could 
make HIV medications less effective (T) 
33 
(69%) 
43 
(90%) 
44 
(92%) 
0.010 0.334 0.002 
15. It is best to stop HIV medications as soon as you feel better 
(F) 
45 
(94%) 
47 
(98%) 
48 
(100%) 
1.00 1.00 1.00 
16. Missing a few doses of HIV pills can increase the amount of 
HIV virus in the body (T) 
25 
(52%) 
44 
(92%) 
45 
(94%) 
< 0.001 0.705 < 0.001 
17. After a few months, it becomes less important to take HIV 
medications at the right time of day (F) 
35 
(73%) 
40 
(83%) 
45 
(94%) 
0.035 0.206 0.002 
18. HIV medications help the body’s immune system get 
stronger (CD4 increase) (T) 
12 
(25%) 
39 
(81%) 
43 
(90%) 
< 0.001 0.248 < 0.001 
19. When HIV medications work well, the HIV viral load 
increases (F) 
37 
(77%) 
46 
(96%) 
45 
(94%) 
0.002 0.317 < 0.001 
20. Taking antibiotic medication protects a person from getting 
infected with HIV (F) 
36 
(75%) 
41 
(81%) 
44 
(92%) 
0.005 0.755 0.002 
21. Physical exercise (e.g., yoga, tai chi) can help reduce stress 
levels in HIV patients (T) 
39 
(81%) 
46 
(96%) 
47 
(98%) 
0.008 0.317 0.011 
Note: The correct answer is indicated by T=True or F=False. Percentages are rounded to the nearest whole number.  
 
